SOCS2 and chronic myelogenous leukemia, BCR-ABL1 positive: In contrast, in bone marrow cells from chronic myeloid leukaemia (CML) patients, SOCS2 is highly expressed and is thus hypothesised to be involved in advanced stages of CML21.